- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
EQL Pharma AB (EQL)
EQL Pharma AB stock price live, this page displays ST EQL stock exchange data. View the EQL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the EQL Pharma AB real time stock price chart below.
What Is the EQL Pharma AB Stock Price Today?
The EQL Pharma AB stock price today is 20.0000.
What Is the Stock Symbol for EQL Pharma AB?
The stock ticker symbol for EQL Pharma AB is EQL.
Is EQL the Same as $EQL?
$EQL is a common way to refer to the EQL Pharma AB ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does EQL Pharma AB Trade On?
EQL Pharma AB is listed and trades on the Stockholm stock exchange.
Is EQL Pharma AB a Good Stock to Buy?
Determining whether EQL Pharma AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current EQL Pharma AB share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EQL quote. (ISIN: SE0005497732)
What Is the EQL Pharma AB Stock Price Today?
The EQL Pharma AB stock price today is 20.0000.
What Is the Stock Symbol for EQL Pharma AB?
The stock ticker symbol for EQL Pharma AB is EQL.
Is EQL the Same as $EQL?
$EQL is a common way to refer to the EQL Pharma AB ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does EQL Pharma AB Trade On?
EQL Pharma AB is listed and trades on the Stockholm stock exchange.
Is EQL Pharma AB a Good Stock to Buy?
Determining whether EQL Pharma AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current EQL Pharma AB share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EQL quote. (ISIN: SE0005497732)
Stockholm
Currency in SEK
20.0000
-1.7000(-7.83%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.3800
21.2500
52 wk Range
17.3800
96.0000
Earnings results expected today
1/4
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.380021.2500
52 wk Range
17.380096.0000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EQL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Price has fallen significantly over the last year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
EQL Pharma AB Earnings Call Summary for Q1/2027
- Q1 sales flat YoY; gross margin fell to 17% from 43% due to SEK 20M inventory write-down and supply issues.
- Operating expenses surged 23% YoY to SEK 31.5M; stock-outs improved from 5-7 products to 1-2 entering Q2.
- Company maintains 15% full-year sales growth target despite weak Q1; expects Q2-Q3 recovery as inventory normalizes.
- Seven product launches planned for 2025; Memprex API switch approval targeted early 2026 to boost margins mid-year.
- CEO calls Q1 'low water mark'; no covenant breach expected but elevated leverage monitored closely amid recovery efforts.
Last Updated: 08/07/2026, 05:16 AM
Read Full TranscriptEarnings
Latest Release
May 08, 2026
EPS / Forecast
0.32 / 0.30
Revenue / Forecast
120.1M / 123.8M
Compare EQL to Peers and Sector
Metrics to compare | EQL | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipEQLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 51.1x | 99.3x | −0.4x | |
PEG Ratio | −0.72 | 3.08 | 0.00 | |
Price / Book | 2.4x | 3.6x | 2.6x | |
Price / LTM Sales | 1.5x | 1.2x | 3.0x | |
Upside (Analyst Target) | 107.4% | 40.7% | 50.7% | |
Fair Value Upside | Unlock | 14.1% | 7.2% | Unlock |
EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers prescription drugs, including hospital products. EQL Pharma AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the EQL Pharma (EQL) Stock Price Today?
The EQL Pharma stock price today is 20.0000 SEK.
What Stock Exchange Does EQL Pharma Trade On?
EQL Pharma is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for EQL Pharma?
The stock symbol for EQL Pharma is "EQL."
What Is the EQL Pharma Market Cap?
As of today, EQL Pharma market cap is 590.5900M SEK.
What Is EQL Pharma's Earnings Per Share (TTM)?
The EQL Pharma EPS (TTM) is 0.4200.
When Is the Next EQL Pharma Earnings Date?
EQL Pharma will release its next earnings report on Aug 07, 2026.
From a Technical Analysis Perspective, Is EQL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has EQL Pharma Stock Split?
EQL Pharma has split 0 times.
How Many Employees Does EQL Pharma Have?
EQL Pharma has 23 employees.
What is the current trading status of EQL Pharma (EQL)?
As of Aug 07, 2026, EQL Pharma (EQL) is trading at a price of 20.0000 SEK, with a previous close of 52.5000 SEK. The stock has fluctuated within a day range of 17.3800 SEK to 21.2500 SEK, while its 52-week range spans from 17.3800 SEK to 96.0000 SEK.
What Is EQL Pharma (EQL) Price Target According to Analysts?
The average 12-month price target for EQL Pharma is 45.0000 SEK, with a high estimate of 45 SEK and a low estimate of 45 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +125.00% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.